# Impact of [18F] PSMA-1007 Imaging for Primary Staging of Prostate Cancer

> **NCT06820333** · — · RECRUITING · sponsor: **Heinrich-Heine University, Duesseldorf** · enrollment: 200 (estimated)

## Conditions studied

- Prostate Cancer (Adenocarcinoma)

## Interventions

_None listed._

## Key facts

- **NCT ID:** NCT06820333
- **Lead sponsor:** Heinrich-Heine University, Duesseldorf
- **Sponsor class:** OTHER
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** RECRUITING
- **Start date:** 2025-01-10
- **Primary completion:** 2030-01-31
- **Final completion:** 2030-01-31
- **Target enrollment:** 200 (ESTIMATED)
- **Last updated:** 2025-02-11


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT06820333

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT06820333, "Impact of [18F] PSMA-1007 Imaging for Primary Staging of Prostate Cancer". Retrieved via AI Analytics 2026-06-24 from https://api.ai-analytics.org/clinical/NCT06820333. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*